当前位置：
X-MOL 学术
›
Int. J. Stroke
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Thrombolysis related symptomatic intracranial hemorrhage in estimated versus measured body weight
International Journal of Stroke ( IF 6.7 ) Pub Date : 2019-05-15 , DOI: 10.1177/1747493019851285 T Truc My Nguyen 1 , Stephanie IW van de Stadt 2 , Adrien E Groot 2 , Marieke JH Wermer 1 , Heleen M den Hertog 3 , Hanneke M Droste 3 , Erik W van Zwet 4 , Sander M van Schaik 5, 6 , Jonathan M Coutinho 2 , Nyika D Kruyt 1
International Journal of Stroke ( IF 6.7 ) Pub Date : 2019-05-15 , DOI: 10.1177/1747493019851285 T Truc My Nguyen 1 , Stephanie IW van de Stadt 2 , Adrien E Groot 2 , Marieke JH Wermer 1 , Heleen M den Hertog 3 , Hanneke M Droste 3 , Erik W van Zwet 4 , Sander M van Schaik 5, 6 , Jonathan M Coutinho 2 , Nyika D Kruyt 1
Affiliation
Acute ischemic stroke patients should receive intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) as quickly as possible for optimal clinical efficacy.1–5 The most feared complication of IVT is symptomatic intracranial hemorrhage (sICH) occurring in 2.7–5.7% of patients.6
中文翻译：
溶栓相关症状性颅内出血的估计值与实测体重
急性缺血性中风患者应尽快接受静脉血栓溶解（IVT）和重组组织纤溶酶原激活剂（rt-PA）的治疗，以取得最佳临床疗效。1–5 IVT最令人担心的并发症是2.7–5.7％的患者发生有症状的颅内出血（sICH）。6
更新日期：2020-02-25
中文翻译：
溶栓相关症状性颅内出血的估计值与实测体重
急性缺血性中风患者应尽快接受静脉血栓溶解（IVT）和重组组织纤溶酶原激活剂（rt-PA）的治疗，以取得最佳临床疗效。1–5 IVT最令人担心的并发症是2.7–5.7％的患者发生有症状的颅内出血（sICH）。6
京公网安备 11010802027423号